Cargando…

Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study

Purpose: The consideration of radiation exposure is becoming more important in metastatic melanoma due to improved prognoses. The aim of this prospective study was to investigate the diagnostic performance of whole-body (WB) magnetic resonance imaging (MRI) in comparison to computed tomography (CT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinert, Christian Philipp, Liang, Cecilia, Weissinger, Matthias, Vogel, Jonas, Forschner, Andrea, Nikolaou, Konstantin, la Fougère, Christian, Seith, Ferdinand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253107/
https://www.ncbi.nlm.nih.gov/pubmed/37296815
http://dx.doi.org/10.3390/diagnostics13111963
_version_ 1785056328526331904
author Reinert, Christian Philipp
Liang, Cecilia
Weissinger, Matthias
Vogel, Jonas
Forschner, Andrea
Nikolaou, Konstantin
la Fougère, Christian
Seith, Ferdinand
author_facet Reinert, Christian Philipp
Liang, Cecilia
Weissinger, Matthias
Vogel, Jonas
Forschner, Andrea
Nikolaou, Konstantin
la Fougère, Christian
Seith, Ferdinand
author_sort Reinert, Christian Philipp
collection PubMed
description Purpose: The consideration of radiation exposure is becoming more important in metastatic melanoma due to improved prognoses. The aim of this prospective study was to investigate the diagnostic performance of whole-body (WB) magnetic resonance imaging (MRI) in comparison to computed tomography (CT) with (18)F-FDG positron emission tomography (PET)/CT and (18)F-PET/MRI together with a follow-up as the reference standard. Methods: Between April 2014 and April 2018, a total of 57 patients (25 females, mean age of 64 ± 12 years) underwent WB-PET/CT and WB-PET/MRI on the same day. The CT and MRI scans were independently evaluated by two radiologists who were blinded to the patients’ information. The reference standard was evaluated by two nuclear medicine specialists. The findings were categorized into different regions: lymph nodes/soft tissue (I), lungs (II), abdomen/pelvis (III), and bone (IV). A comparative analysis was conducted for all the documented findings. Inter-reader reliability was assessed using Bland–Altman procedures, and McNemar’s test was utilized to determine the differences between the readers and the methods. Results: Out of the 57 patients, 50 were diagnosed with metastases in two or more regions, with the majority being found in region I. The accuracies of CT and MRI did not show significant differences, except in region II where CT detected more metastases compared to MRI (0.90 vs. 0.68, p = 0.008). On the other hand, MRI had a higher detection rate in region IV compared to CT (0.89 vs. 0.61, p > 0.05). The level of agreement between the readers varied depending on the number of metastases and the specific region, with the highest agreement observed in region III and the lowest observed in region I. Conclusions: In patients with advanced melanoma, WB-MRI has the potential to serve as an alternative to CT with comparable diagnostic accuracy and confidence across most regions. The observed limited sensitivity for the detection of pulmonary lesions might be improved through dedicated lung imaging sequences.
format Online
Article
Text
id pubmed-10253107
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102531072023-06-10 Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study Reinert, Christian Philipp Liang, Cecilia Weissinger, Matthias Vogel, Jonas Forschner, Andrea Nikolaou, Konstantin la Fougère, Christian Seith, Ferdinand Diagnostics (Basel) Article Purpose: The consideration of radiation exposure is becoming more important in metastatic melanoma due to improved prognoses. The aim of this prospective study was to investigate the diagnostic performance of whole-body (WB) magnetic resonance imaging (MRI) in comparison to computed tomography (CT) with (18)F-FDG positron emission tomography (PET)/CT and (18)F-PET/MRI together with a follow-up as the reference standard. Methods: Between April 2014 and April 2018, a total of 57 patients (25 females, mean age of 64 ± 12 years) underwent WB-PET/CT and WB-PET/MRI on the same day. The CT and MRI scans were independently evaluated by two radiologists who were blinded to the patients’ information. The reference standard was evaluated by two nuclear medicine specialists. The findings were categorized into different regions: lymph nodes/soft tissue (I), lungs (II), abdomen/pelvis (III), and bone (IV). A comparative analysis was conducted for all the documented findings. Inter-reader reliability was assessed using Bland–Altman procedures, and McNemar’s test was utilized to determine the differences between the readers and the methods. Results: Out of the 57 patients, 50 were diagnosed with metastases in two or more regions, with the majority being found in region I. The accuracies of CT and MRI did not show significant differences, except in region II where CT detected more metastases compared to MRI (0.90 vs. 0.68, p = 0.008). On the other hand, MRI had a higher detection rate in region IV compared to CT (0.89 vs. 0.61, p > 0.05). The level of agreement between the readers varied depending on the number of metastases and the specific region, with the highest agreement observed in region III and the lowest observed in region I. Conclusions: In patients with advanced melanoma, WB-MRI has the potential to serve as an alternative to CT with comparable diagnostic accuracy and confidence across most regions. The observed limited sensitivity for the detection of pulmonary lesions might be improved through dedicated lung imaging sequences. MDPI 2023-06-05 /pmc/articles/PMC10253107/ /pubmed/37296815 http://dx.doi.org/10.3390/diagnostics13111963 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Reinert, Christian Philipp
Liang, Cecilia
Weissinger, Matthias
Vogel, Jonas
Forschner, Andrea
Nikolaou, Konstantin
la Fougère, Christian
Seith, Ferdinand
Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study
title Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study
title_full Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study
title_fullStr Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study
title_full_unstemmed Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study
title_short Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study
title_sort whole-body magnetic resonance imaging (mri) for staging melanoma patients in direct comparison to computed tomography (ct): results from a prospective positron emission tomography (pet)/ct and pet/mri study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253107/
https://www.ncbi.nlm.nih.gov/pubmed/37296815
http://dx.doi.org/10.3390/diagnostics13111963
work_keys_str_mv AT reinertchristianphilipp wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy
AT liangcecilia wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy
AT weissingermatthias wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy
AT vogeljonas wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy
AT forschnerandrea wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy
AT nikolaoukonstantin wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy
AT lafougerechristian wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy
AT seithferdinand wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy